Humanoid portfolio co. RideScan files patent in U.K.

Executive Summary

• RideScan Ltd. filed a foundational patent application with the UK Intellectual Property Office to protect its AI‑driven risk scoring and anomaly detection technology for robotics.
• The company is launching pilot deployments with a cohort of 10 organizations to integrate its API, aiming to demonstrate reduced robot downtime and enhanced safety.
• RideScan secured £50,000 from Innovate U.K.’s Growth Catalyst Early Stage grant (execution starting Nov 1 2025) and an additional £40,000 angel investment from a Europe‑based deep‑tech syndicate.

Key Details

• Patent Filing: Foundational patent application submitted to the United Kingdom Intellectual Property Office covering RideScan’s independent risk scoring and anomaly detection methodology.
• Pilot Cohort: 10 selected organizations (research institutions and corporate robotics teams) will integrate RideScan’s API across various humanoid, robot, and industrial platforms to validate health‑monitoring capabilities.
• Grant Funding: £50,000 awarded by Innovate U.K.’s Growth Catalyst Early Stage “new innovators” grant; funds earmarked for commercialization activities beginning 1 Nov 2025.
• Angel Investment: Additional £40,000 investment from a Europe‑based deep‑tech angel syndicate that includes scientists from an AI research subsidiary of a Fortune 500 company.
• Strategic Goal: Demonstrate ability to reduce robot downtime, improve operational safety, and uncover hidden anomalies missed by traditional monitoring systems.
• Quotes:
• Dr. Nandakumar (CEO, RideScan): Emphasized the patent filing as a major step toward protecting technology and highlighted upcoming pilots to transform robot deployments.
• Shahab Samimi (CEO, Humanoid Global): Stated that the progress fortifies the portfolio’s focus on safe, scalable robotics and positions RideScan as a cornerstone for trustworthy AI‑driven deployments.

Notable Quotes

• “At RideScan, we continue to progress our mission to ensure every robot can be trusted to operate safely and reliably,” – Dr. Nandakumar, CEO, RideScan.
• “We believe that this progress not only fortifies our portfolio's focus on safe, scalable robotics but also positions RideScan as a cornerstone in enabling trustworthy AI‑driven deployments worldwide.” – Shahab Samimi, CEO, Humanoid Global.